Administration of alpha lipoic acid in DN patients reduces oxidative stress via inhibition of NF-κβ and inflammatory cytokines such as TNF-α and IL-8 (Lv et al., 2015). This evidence concerns the gene NFKB1 and liver dysplastic nodule.